美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=ORLADEYO"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
ORLADEYO 214094 001 NDA BEROTRALSTAT DIHYDROCHLORIDE CAPSULE;ORAL EQ 110MG BASE Yes No 2020/12/03 2020/12/03 BIOCRYST Prescription
ORLADEYO 214094 002 NDA BEROTRALSTAT DIHYDROCHLORIDE CAPSULE;ORAL EQ 150MG BASE Yes Yes 2020/12/03 2020/12/03 BIOCRYST Prescription
ORLADEYO 219776 001 NDA BEROTRALSTAT DIHYDROCHLORIDE PELLETS;ORAL EQ 72MG BASE/PACKET Yes No 2025/12/11 2025/12/11 BIOCRYST Prescription
ORLADEYO 219776 002 NDA BEROTRALSTAT DIHYDROCHLORIDE PELLETS;ORAL EQ 96MG BASE/PACKET Yes No 2025/12/11 2025/12/11 BIOCRYST Prescription
ORLADEYO 219776 003 NDA BEROTRALSTAT DIHYDROCHLORIDE PELLETS;ORAL EQ 108MG BASE/PACKET Yes No 2025/12/11 2025/12/11 BIOCRYST Prescription
ORLADEYO 219776 004 NDA BEROTRALSTAT DIHYDROCHLORIDE PELLETS;ORAL EQ 132MG BASE/PACKET Yes Yes 2025/12/11 2025/12/11 BIOCRYST Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2026 DrugFuture->U.S. FDA Drugs Database